Literature DB >> 6440883

The plasmids of Haemophilus ducreyi.

P J McNicol, A R Ronald.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6440883

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  15 in total

Review 1.  Antimicrobial susceptibility of Haemophilus ducreyi.

Authors:  Y Dangor; R C Ballard; S D Miller; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.

Authors:  M J Sanson-Le Pors; I M Casin; M C Thebault; G Arlet; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Treating chancroid with enoxacin.

Authors:  W Naamara; D Y Kunimoto; L J D'Costa; J O Ndinya-Achola; H Nsanze; A R Ronald; F A Plummer
Journal:  Genitourin Med       Date:  1988-06

4.  Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.

Authors:  K S MacDonald; D W Cameron; L D'Costa; J O Ndinya-Achola; F A Plummer; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Asymptomatic carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction.

Authors:  S Hawkes; B West; S Wilson; H Whittle; D Mabey
Journal:  Genitourin Med       Date:  1995-08

6.  Novel plasmid combinations in Haemophilus ducreyi isolates from Thailand.

Authors:  S K Sarafian; S R Johnson; M L Thomas; J S Knapp
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

7.  Rapid control of a chancroid outbreak: implications for Canada.

Authors:  P G Jessamine; R C Brunham
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

8.  Single-dose ceftriaxone for chancroid.

Authors:  M I Bowmer; H Nsanze; L J D'Costa; J Dylewski; L Fransen; P Piot; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

9.  In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.

Authors:  N M Le Saux; L A Slaney; F A Plummer; A R Ronald; R C Brunham
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 10.  Biology of Haemophilus ducreyi.

Authors:  W L Albritton
Journal:  Microbiol Rev       Date:  1989-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.